Dolutegravir
Side effects
Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Hyperglycaemia | 12% | x | ||
| Alanine aminotransferase increased | 8% | x | ||
| Headache | 1% - 14% | x | x | |
| Insomnia | 1% - 3% | x | x | |
| Nausea | 1% - 15% | x | x | |
| Diarrhoea | 1% - 16% | x | x | |
| Dizziness | 1% - 5% | x | x | |
| Rash | 0% - 6% | x | x | |
| Abnormal dreams | 1% - 2% | x | x | |
| Vertigo | 0% - 2% | x | ||
| Abdominal pain | x | x | ||
| Autoimmune disorder | x | |||
| Mental disorder | x | |||
| Drug eruption | x | |||
| Fatigue | x | x | ||
| Flatulence | x | x | ||
| Gastrointestinal disorder | x | x | ||
| Basedow's disease | x | |||
| Hepatitis | x | x | ||
| Hepatitis C | x | |||
| Hypersensitivity | x | x | ||
| Immune system disorder | x | |||
| Inflammation | x | |||
| Musculoskeletal disorder | x | |||
| Myositis | x | |||
| Nervous system disorder | x | |||
| Neutropenia | x | |||
| Opportunistic infection | x | |||
| Prurigo | x | |||
| Pruritus | x | x | ||
| Urinary tract disorder | x | |||
| Vomiting | x | x | ||
| Unspecified disorder of skin and subcutaneous tissue | x | x | ||
| Rash macular | x | |||
| Abdominal discomfort | x | x | ||
| Abdominal pain upper | x | x | ||
| Hepatobiliary disease | x | x | ||
| Rash maculo-papular | x | |||
| Rash generalised | x | |||
| Serum creatinine increased | x | x | ||
| Bilirubin total increased | x | |||
| Fat redistribution | x | |||
| Renal impairment | x | |||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
